Category Archives: New Resources

Roundup of R15 Academic Research Enhancement Award (AREA) and Research Enhancement Award Program (REAP) Resources

Posted on by
Reply

As announced in this guide notice, NIH now administers two programs using the R15 activity code. The Academic Research Enhancement Award (AREA) targeting undergraduate-focused institutions and the Research Enhancement Award Program (REAP) targeting graduate schools of arts and sciences and health professional schools that grant baccalaureate or advanced degrees. Continue reading →

Is My Ancillary Study Considered a Clinical Trial?

Posted on by
Reply

It depends. Yes; if the ancillary study adds an additional prospectively assigned intervention to patients or a sub-population of patients within the larger clinical trial and all elements of the NIH clinical trial definition are met. No; if the ancillary study is only adding additional measures to an existing clinical trial. Continue reading →

New Resources Available for Basic Experimental Studies with Humans (BESH) Funding Opportunities

Posted on by
Reply

In November, NIH announced the publication of new funding opportunities specifically for Basic Experimental Studies Involving Humans (BESH). Need help determining if your research fits within the scope of a BESH funding opportunity announcement (FOA)? Check out these new resources. Continue reading →

New “All About Grants” Podcast on Preparing for Private Investment

Posted on by
Reply

Wondering how to knock that investor pitch out of the park? In this next installment of the “All About Grants” podcast series, small business innovators will get a front row seat to hear how to prepare for private investment. Dr. Ethel Ruben, NIH’s Entrepreneur-In-Residence, steps up to the plate and shares insights on who these investors are, how they decide on what innovations to invest in the biomedical commercial space, and some valuable tips and tricks to improve the accuracy of your investor pitch. Continue reading →